| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.21 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |